Postpartum psychiatric disorders are heritable, but how genetic liability varies by other significant risk factors is unknown. We aimed to (1) estimate associations of genetic risk scores (GRS) for major depression (MD), bipolar disorder (BD), and schizophrenia (SCZ) with postpartum psychiatric disorders, (2) examine differences by prior psychiatric history, and (3) compare genetic and familial risk of postpartum psychiatric disorders. We conducted a nested case-control study based on Danish population-based registers of all women in the iPSYCH2012 cohort who had given birth before December 31, 2015 (n = 8850). Cases were women with a diagnosed psychiatric disorder or a filled psychotropic prescription within one year after delivery (n = 5829 cases, 3021 controls). Association analyses were conducted between GRS calculated from Psychiatric Genomics Consortium discovery meta-analyses for MD, BD, and SCZ and case-control status of a postpartum psychiatric disorder. Parental psychiatric history was associated with postpartum psychiatric disorders among women with previous psychiatric history (OR, 1.14; 95% CI 1.02–1.28) but not without psychiatric history (OR, 1.08; 95% CI: 0.81–1.43). GRS for MD was associated with an increased risk of postpartum psychiatric disorders in both women with (OR, 1.44; 95% CI: 1.19–1.74) and without (OR, 1.88; 95% CI: 1.26–2.81) personal psychiatric history. SCZ GRS was only minimally associated with postpartum disorders and BD GRS was not. Results suggest GRS of lifetime psychiatric illness can be applied to the postpartum period, which may provide clues about distinct environmental or genetic elements of postpartum psychiatric disorders and ultimately help identify vulnerable groups.
The postpartum period is one of the most vulnerable times for psychiatric illness in a woman’s life1,2,3 and is associated with a highly increased risk of depression and other disorders3,4,5,6,7,8. Postpartum psychiatric disorders vary in prevalence, severity, and timing of onset, and have a wide spectrum of clinical symptoms9,10,11,12,13. They include unipolar depression, which is common and occurs in ~10–15% of postpartum women14 and more rare and severe disorders like bipolar disorder occurring in 3% of postpartum women15, and postpartum psychosis that occurs in 1 to 2 per 1000 in the first few weeks after delivery3,16,17. Personal2,4,5,6,18,19 and family history20,21,22,23,24,25,26 of psychiatric illness are two of the strongest risk factors for postpartum psychiatric disorders. A strong association between family history and postpartum psychiatric disorders suggests genetic vulnerability for these disorders, which has been confirmed in a recent heritability study of perinatal depression27. Moreover, heritability of postpartum depression may be greater than that of major depression outside of the perinatal period (44% versus 32%)27.
Genetic liability can be estimated as genetic risk scores (GRS), a score produced for each individual by weighting the effect size of multiple risk alleles obtained from genetic association studies28. Increasingly robust findings from genetic association studies have been used to construct GRS for major depression (MD)29, bipolar disorder (BD)30, and schizophrenia (SCZ)31 and evaluate shared genetic risk between psychiatric traits32,33,34. Thus far, a single study has considered GRS and risk of postpartum depression and found that BD GRS was more strongly associated with postpartum depression than major depression outside the postpartum period (R2 = 1.64%, p = 3.04 × 10−5 versus R2 = 0.4%, p = 0.02)35. While genetic risk scores have been applied to postpartum psychiatric disorders to evaluate genetic overlap with other psychiatric disorders35, they have not been used to explore how these correlations differ by other risk factors. Assessing how genetic liability varies by specific and significant risk factors may help identify subgroups with shared etiology.
We aimed to determine whether genetic risk scores for MD, BD, and SCZ predict psychiatric disorders occurring specifically in the postpartum period. Building on prior work, we also sought to examine how risk score predictions differ in women with a prior psychiatric history or without, and how genetic risks compare to risks associated with family history of psychiatric disorders.
Materials and methods
Data from Danish population-based registers were linked by unique personal identification numbers, which are assigned to all live-born children and new residents in Denmark and enable linkage across all national registers. We conducted a case-control study selected from the larger iPSYCH2012 study sample, for which sample selection36 and genetic analytic methods34 have been described elsewhere (Supplementary Methods). Briefly, the iPSYCH2012 sample was selected from the Danish Civil Registration System36 of all singleton births born between May 1st, 1981 and December 31st, 2005 who were alive and resided in Denmark at one year of age and whose mother was known. The full cohort was then linked to the Danish Psychiatric Central Research Register37. All subjects within the full cohort who had a diagnosis of SCZ, autism spectrum disorder, attention-deficit/hyperactivity disorder, BD, and affective disorder were identified as cases in the iPSYCH2012 sample (N = 57,377). A random sample of 30,000 subjects (i.e., the subcohort), was selected from the full cohort from which the cases were drawn (Fig. 1)36. This random sample represents a population sample to be used as controls in the genetic analysis. However, since these 30,000 subjects were chosen randomly from the full cohort, some also have psychiatric disorders.
For the current study, eligible study subjects were all women born during 1981–1999 and included in the iPSYCH2012 study sample who gave birth to at least one child before December 31st, 2015 and passed genetic quality control (N = 8931) (Fig. 1). We excluded 11 women who emigrated before their first delivery and 70 women that could not be linked to their fathers in the register. Altogether 8850 women were included in our final analysis.
Postpartum psychiatric disorders
We defined a postpartum psychiatric disorder either as (1) a treated psychiatric episode recorded in the Danish Psychiatric Central Research Register or (2) at least one redeemed prescription of psychotropic drugs recorded in the Danish National Prescription Registry within 12 months after delivery. Consequently, our case group consisted of moderate (prescription defined) and severe (treated in secondary health care and diagnosed by a psychiatrist) cases (Supplementary Table S1). We selected the time period of interest as one year after childbirth to account for a potential delay in seeking psychiatric care and to apply a widely used clinical definition38. Prior work in these data showed similar familial risk of postpartum psychiatric disorders at 3, 6, and 12 months postpartum39. A postpartum psychiatric episode may represent a new-onset disorder, a continuation or recurrence of a psychiatric disorder prior to childbirth, or a different psychiatric disorder after childbirth in a woman who had a prior psychiatric disorder.
The Danish Psychiatric Central Research Register contains information on inpatient contacts at psychiatric hospitals and psychiatric wards from 1969 onwards. Psychiatric outpatient treatment and emergency room contacts have been included since 199537. Treated psychiatric episodes included any psychiatric diagnosis (Primary diagnosis, ICD-10 codes F00–F99), excluding mental retardation and substance abuse (ICD-10 codes F10–F19 and F70–F79). The Danish National Prescription Registry was established in 1995, and contains information on all prescriptions dispensed at community pharmacies in Denmark40. We included psychotropic drugs of Anatomical Therapeutic Chemical (ATC) classification codes N05 (psycholeptics) and N06 (psychoanaleptics). Detailed diagnostic codes and categorization are described in the Supplementary Methods.
Personal and parental psychiatric history
We defined previous personal psychiatric history as one in-patient or out-patient treatment for the psychiatric disorders described above or one redeemed prescription for psychotropic medications before the date of delivery. We similarly defined parental psychiatric history as one in-patient or out-patient treatment for psychiatric disorders in a mother or father before the date of delivery. Note, as information on prescriptions only dates back to 1995, prescription data were not used to define parental psychiatric history.
Genotyping, quality control, and imputation
The Danish Newborn Screening Biobank stored dried blood spots taken at birth from nearly all infants born in Denmark since May 1st 198141. Genetic data were extracted from the dried blood spot samples stored in this biobank, whole-genome amplified (in triplicate using the Qiagen REPLI-g mini kit and the three separate reactions were pooled), and genotyped with Illumina Infinium HD Human610-Quad BeadChip42. Information about non-genotyped markers was obtained by imputation using the 1000 genomes phase 3 as reference panel. Quality control and imputation were conducted using the Ricopili pipeline43 (Supplementary Methods).
Genetic risk scores
We calculated genetic risk scores for MD29, BD30, and SCZ44 based on genome-wide data from Psychiatric Genomics Consortium (PGC) discovery sample excluding individuals in the iPSYCH2012 sample. We selected single nucleotide polymorphisms (SNPs) associated with MD, BP, and SCZ at a P-value threshold of 0.05 or lower, which were reported as maximising out-of-sample prediction into multiple cohorts of the study specific disorders (Supplementary Table S2)44,45,46 and generated the polygenic risk score for each individual based on this threshold (See Grove et al.34 and Supplementary Methods for details).
Chi-squared tests were used to evaluate differences in characteristics between cases and controls in the overall cohort and among women with or without prior psychiatric history, except in the case of maternal age at index delivery, in which age distributions were compared with t-tests. Binary logistic regression models were used to estimate the odds ratios (ORs) of postpartum psychiatric disorders with 95% confidence intervals (CIs) using Stata 13.1. We converted genetic risk scores into z-scores according to the means and standard deviations from the distributions in women born during 1981–1999 from the subcohort based on the following formula: (observed value − mean)/standard deviation. We analyzed standardized genetic risk scores as continuous variables, reported as a unit change for one standard deviation or 10 deciles, and categorically by decile with the lowest decile as the reference group. To account for ancestry differences, we adjusted for the first four principal components estimated from genome-wide SNP genotypes in all models47. To address the possible secular trends in diagnostic practices and to account for the fact that fewer blood spots were retrievable among women born in the earlier years, we also included woman's calendar year of birth as a covariate in all models. In the adjusted models, we included parental psychiatric history before the index delivery, parental country of origin, primiparity, age and age-squared at the index delivery as additional covariates. Because approximately 9% of the sample had a parent born outside of Denmark, and thus, may be of mixed ancestry, we conducted a sensitivity analysis restricting to women only with parents of Danish origin. We present results in the overall cohort but also stratified by women with or without psychiatric history prior to childbirth, as first onset and recurrent postpartum psychiatric disorders may reflect different phenotypes. We tested for statistical interaction between GRS and psychiatric history to assess whether the associations between GRS and postpartum psychiatric disorders were modified by previous psychiatric history. To account for multiple corrections, we applied a Bonferroni corrected P-value of 0.017 for α = 0.05 and three independent tests (MD, BD, and SCZ GRS). We computed area under the covariate-adjusted receiver-operator characteristic (ROC) curve to evaluate the ability of the GRS for MD, BD, and SCZ to predict postpartum psychiatric disorder case status.
Our primary outcome of interest was a psychiatric disorder in the postpartum period, but to test to which extent genetic risk scores in general predict psychiatric disorders in our sample, we also conducted an analysis in which cases consisted of psychiatric disorders at any time point and controls were individuals free of psychiatric disorders at any time.To determine whether results were influenced by the P-value threshold used to select SNPs from the discovery sample for inclusion in the risk score, we repeated our analysis using all SNPs (PT ≤ 1). Because our broad case definition might also influence results, we conducted a sensitivity analysis in which we categorized postpartum psychiatric disorders into two mutually exclusive subsets defined by severity of the postpartum disorder: (1) hospital contact regardless of psychotropic treatment and (2) only psychotropic medication use.
The study was approved by the Danish Scientific Ethical Committee System, the Danish Data Protection Agency, and the Danish Neonatal Screening Biobank Steering Committee. By Danish law, no informed consent is required for a register-based study on the basis of anonymized data. The study was also approved by the Institutional Review Board at the University of North Carolina at Chapel Hill.
The final dataset consisted of 8850 women who had at least one recorded childbirth. Median age was 25.0 (interquartile range: 23.0–28.8) years and the majority were primiparous (64.4%). The sample included 479 postpartum psychiatric disorder cases and 1840 non-cases among women with no previous personal psychiatric history, and 2542 postpartum psychiatric disorder cases and 3989 non-cases among women with previous personal psychiatric history (Table 1). Cases in the sample consisted predominantly of those defined by unipolar depression diagnosis or redeemed prescription for antidepressants; 343 of 479 cases (71.6%) among women with no previous personal psychiatric history, and 1540 of 2542 cases (60.6%) among women with previous personal psychiatric history had either in- or outpatient treatment for depression or redeemed prescription for antidepressants. Compared to non-cases, cases of postpartum psychiatric disorders were more likely to have parental psychiatric history (P < 0.001) and to be younger (P < 0.001) and primiparous (P < 0.001).
After controlling for potential confounders, parental psychiatric history was associated with a higher risk of postpartum psychiatric disorders among women with previous personal psychiatric history (OR: 1.14, 95% CI: 1.02–1.28) but not among women without personal psychiatric history (OR: 1.08, 95% CI: 0.81–1.43). An increased risk was observed in primiparous women, OR: 2.42 (95% CI: 2.14–2.74) and 1.63 (95% CI: 1.27–2.11) for women with and without prior personal psychiatric history, respectively (Table 2) (Full model, Supplementary Table S3).
Genetic risk score for MD significantly predicted postpartum psychiatric disorders as well as psychiatric disorders at any time point. A 10-decile increase in MD GRS was associated with an increased risk of postpartum psychiatric disorders (OR: 1.73, 95% CI: 1.46–2.05), in both women with no personal psychiatric history (OR: 1.88, 95% CI: 1.26–2.81) and women with personal psychiatric history (OR: 1.44, 95% CI: 1.19–1.74). Risk of postpartum psychiatric disorders was significantly increased for the highest deciles of MD GRS compared to the lowest decile. (Table 3, Fig. 2a) (Full models in Supplementary Tables S4, S5, S6; Models by decile, Supplementary Table S7). Adjusted pseudo-R2 was 0.40% for MD GRS among women with no prior personal psychiatric history and 0.20% among women with previous personal psychiatric history. Area under the covariate-adjusted ROC curve (AUC) was 0.54 (95% CI: 0.52–0.58) for MD GRS to predict postpartum psychiatric disorders among women with no prior personal psychiatric history and 0.52 (95% CI: 0.51–0.54) among women with previous psychiatric history (Fig. S1). Associations between MD GRS and psychiatric disorders at any time (OR 2.48, 95% CI: 2.06–2.99) (Table 3; by decile, Supplementary Table S8) were stronger than associations with postpartum disorders (P-value for OR difference was 0.007).
We found no associations between GRS for BD and postpartum psychiatric disorders, either overall or stratified by psychiatric history (Table 3, Fig. 2b). There was a slight association between GRS for SCZ and postpartum psychiatric disorders overall (Table 3, Fig. 2c). Pseudo-R2 for BD and SCZ GRS were small (Table 3) and AUC for BD and SCZ GRS to predict postpartum psychiatric disorders was smaller than that of MD GRS (Supplementary Figs. S2, S3). In our analysis of cases of psychiatric disorders at any time, we found GRS for BD and SCZ predicted psychiatric disorders, though less strongly than for GRS MD.
We observed similar trends between GRS and postpartum psychiatric disorders when we generated scores from SNPs with P ≤ 1.0 in the GWAS training-set (Supplementary Table S9). We found no significant differences when restricting only to women with parents of Danish origin (Supplementary Table S10).
Summary of results
In a large sample of women who had given birth, we found that genetic risk score for lifetime MD was associated with postpartum psychiatric episodes in both women with no psychiatric history (OR: 1.88, 95% CI: 1.26–2.81 for a 10-decile increase in GRS) and women with psychiatric history (OR: 1.44, 95% CI: 1.19–1.74 for a 10-decile increase in GRS). In contrast, we found no significant associations between BD risk scores and postpartum psychiatric episodes. We found small associations between SCZ risk scores and postpartum disorders in the cohort unstratified by psychiatric history. Previously identified risk factors for postpartum psychiatric disorders including primiparity and family history were confirmed in our sample.
Utility of a GRS
Prior studies have shown MD GRS based on the PGC discovery sample to be a strong predictor of major depression in several other target samples46 suggesting the utility of MD GRS as a tool to investigate how additional risk factors may influence risk of MD in genetically susceptible groups, as has been done for other disorders such as schizophrenia48. As our cases predominantly consist of depression diagnoses and women prescribed antidepressants, it is encouraging that MD GRS predicts psychiatric episodes in our target sample. However, both the pseudo-R2 of MD GRS and AUC of MD GRS to predict postpartum psychiatric episodes were small, indicating that MD GRS should not yet be used in a clinical setting to assess risk of postpartum psychiatric episodes. Increasingly large MD discovery samples are necessary to construct accurate predictive GRS, and replication in multiple perinatal populations will be required before GRS can be employed for screening or therapeutic interventions.
Previously identified risk factors including primiparity and family history of psychiatric disorders were confirmed in our sample. Information about these risk factors is easily attained through patient inquiry and medical record review and is currently the best information available for evaluating risk of postpartum psychiatric disorders in a clinical setting. Nonetheless, associations between MD GRS and postpartum psychiatric disorders indicate that the GRS may provide information about genetic liability for psychiatric illness in addition to family history. In particular, the effect of family history remains unchanged with addition of a MD GRS into the model, and there are significant independent associations of MD GRS with postpartum psychiatric disorder case status in both women with and women without prior personal psychiatric history (Supplementary Table S4). In addition, among women with no previous psychiatric history there is an independent association of MD GRS with postpartum psychiatric disorders, even in the absence of an association of parental psychiatric history (Supplementary Table S4), though this may be an artifact of greater statistical power to detect associations with GRS, a continuous variable, than parental psychiatric history, a dichotomous variable.
The one other study applying GRS to postpartum psychiatric disorders compared postpartum depression cases to population controls and separately compared postpartum depression cases to controls who had given birth. They found that BD GRS explained more variance and was more significant for the subset of women who had given birth than in the sample using population controls (R2 = 1.64%, P = 3.04 × 10−5 versus R2 = 1.03%, P = 1.75 × 10−4)35. Importantly, adequate sample sizes of genotyped cases of postpartum depression (PPD) for a GWAS will enable construction of a PPD-specific GRS, but in the meantime, our study provides evidence that GRS for lifetime major depression can be applied in a postpartum population. Although still infeasible for direct application in a perinatal mental health clinical setting, genetic risk scores are being used for research in several disease areas to determine whether people in different strata on the genetic risk distribution differ by response to treatment49 or likelihood to be appropriately captured by screening guidelines50 and are a step toward precision medicine.
Comparison with previous results
Interestingly, we did not find an expected association with BD GRS. Prior epidemiologic work demonstrates postpartum psychiatric illness may share more features with bipolar disorder than other psychiatric disorders20,21,22,23,39,51, particularly for postpartum psychosis7,52,53,54,55. In the study applying genetic risk scores to PPD, Byrne et al. found a stronger genetic relationship between PPD and BD than PPD and MD by applying genetic risk scores for MD and BD35. We hypothesize that the Byrne et al. findings were not replicated in our sample for several reasons. First, case and sample selection differed in the studies. Postpartum psychiatric episodes are heterogeneous and the majority of cases in our sample are most similar to major depression; we would expect stronger associations with the MD GRS. The outcome of PPD in Byrne et al. is also based primarily on self-reported symptoms on the Edinburgh Postnatal Depression Scale56 collected in community samples (i.e., not enriched for women seeking in- or out-patient treatment). Second, since the Byrne et al. study was conducted, larger MD GWAS sample sizes have identified new genome-wide significant loci, producing a more powerful MD GRS that explains more variance in genetic liability. Thus, the stronger associations with the MD GRS than BD GRS may be due to the improved statistical power of the MD score.
Unique concerns and characteristics of investigating genetic etiology of postpartum psychiatric disorders
We applied a broad case definition of postpartum psychiatric disorders, comprising a spectrum of psychiatric diagnoses identified by hospital diagnoses and psychotropic prescriptions and occurring within the first year after childbirth. Although more heterogeneous, we applied a broad definition to ensure we were capturing cases that may be missed in hospital registries, examine similarities and differences with other psychiatric disorders, overcome sample size limitations, and provide a comparable definition to other studies.
Prior studies suggest the etiology of psychiatric episodes occurring immediately after childbirth may differ from later psychiatric episodes3,7,23,51, and future work will investigate potential underlying genetic differences as sample sizes grow. Although the first year postpartum may not identify a specific etiologic cut-point, it is a commonly used clinical definition of postpartum psychiatric disorders38 and enables detection of women that may delay seeking care. Additionally, in our prior work in a similar cohort, we compared associations of family psychiatric history and postpartum psychiatric disorders at three, six, and twelve months after childbirth and found few differences among the time points39, indicating it is reasonable to assess genetic and familial predictors of postpartum psychiatric disorders within the first year after childbirth in this setting. Including the entire first year postpartum can also improve statistical power. Although our sample was selected from a large population-based cohort, sample sizes of women who had given birth were still relatively small.
In Denmark, 85–90% of first depression treatment among people aged 15–44 occurs in a primary care setting57, and limiting our cases to only hospital-based psychiatric diagnoses will underrepresent individuals susceptible to mental illness, particularly depression. Therefore, our definition of psychiatric disorders included both hospital diagnosed cases and women who used antidepressant medications. This broader definition aligns with the concept of major depression operationalized by the PGC, which was the source of the summary statistics for the GRS scores. To better understand the genetic architecture of depression and take advantage of existing genomic resources, the PGC has adopted the concept of ‘major depression’ to establish case status, which includes self-declared depression and is broader than major depressive disorder meeting DSM criteria obtained by clinical interview58. However, we also acknowledge that a hospital-based diagnosis is more specific and antidepressant medications may be prescribed for conditions other than depression. In Denmark, depression is recorded as the indication for 59% of antidepressant prescriptions57. Examining differences by case source may provide information about how including psychotropic prescriptions influence results and also genetic homogeneity by severity, so we conducted a sensitivity analysis categorizing postpartum psychiatric disorders into those defined by hospital diagnosis (Supplementary Table S11a) and psychotropic medication use (Supplementary Table S11b). We found no strong evidence for heterogeneity by subset, however, effect sizes were slightly larger for MD GRS among those defined only by psychotropic medication use, further supporting the similarity of our definition with that of major depression used by the PGC.
While most similar to major depression, our broad definition of postpartum psychiatric disorders included a spectrum of heterogeneous diagnoses that may have different underlying etiology. Prior work has shown that these psychiatric disorders are genetically correlated59, and GRS for one psychiatric disorder can be informative for predicting another60, but we did not have ample statistical power to assess specific diagnoses separately.
There are several hypotheses about the development of psychiatric disorders following childbirth. One is that additional stressors of childbirth and the postpartum period exacerbate an underlying vulnerability of mental illness. Another is that some women are sensitive to hormonal changes occurring near childbirth61,62,63. To probe these hypotheses and consider childbirth as a potential trigger, we investigated associations between genetic vulnerability for psychiatric disorders and postpartum disorders in the overall cohort and then stratified by psychiatric history prior to childbirth. We found little evidence of statistical differences by prior psychiatric history, but we present stratified results because psychiatric history is such a significant risk factor for postpartum psychiatric disorders6 and may provide insight about new-onset postpartum disorders. Tests for interaction generally have low power to reject homogeneity64 but this is the largest existing study in this area, and trends observed in women with and without prior psychiatric history can provide the opportunity for comparison in future studies.
In the analyses assessing the outcome of postpartum psychiatric disorders in the full cohort and among women with previous psychiatric history, the control groups included women with psychiatric diagnoses prior to childbirth, which is likely to weaken an association between MD GRS and postpartum psychiatric episodes. Even within these groups, we saw a significant association which may provide further evidence of enhanced genetic vulnerability for postpartum psychiatric disorders. Postpartum disorders were our primary outcome of interest, but to determine how much limited power influenced the ability to detect associations for BD and SCZ risk scores, and understand how including women with psychiatric diagnoses as controls may have influenced our results in women with previous psychiatric history, we conducted an additional analysis comparing all women in our cohort with psychiatric disorders at any time (N = 7010) with all women without any psychiatric history at any time (i.e., ‘clean controls’) (N = 1840). We found that risk scores for BD and SCZ did predict the outcome of lifetime psychiatric disorders in our sample, however, associations were less strong than for MD (Table 3, Supplementary Table S8).
We also found that associations between MD GRS and psychiatric disorders were stronger for psychiatric disorders at any time than in our primary analyses of postpartum disorders. One might expect these associations to be stronger and more precise since the sample is larger, the controls contain no prior psychiatric episodes, and the cases include women with psychiatric disorders before childbirth, which may occur earlier and indicate greater susceptibility to mental illness. Our results provide evidence that the underlying genetic vulnerability of postpartum disorders in our sample is most similar to that of major depression, but we canot not determine if differences in strength of the associations are due to the sample size, sampling framework, or underlying etiologic and genetic differences. Future studies enabling an analysis of a GRS specifically for postpartum psychiatric disorders will help distinguish whether there are unique genetic features of postpartum disorders and potentially identify vulnerable risk groups both within and outside of the postpartum period.
Strengths and Limitations
This study has several other limitations. The oldest participants in our study are 34 years with a mean age of 25.9 years (SD 3.8), representing a relatively young cohort that potentially limits generalizability to other age groups. Additionally, most of the sample was primiparous, and thus lifetime risk of postpartum psychiatric disorders would not necessarily have been captured by these first births. The iPSYCH case selection influenced the proportion and prevalence of specific psychiatric diagnoses in the parent study36, resulting in more cases than controls and a higher proportion of severe psychiatric disorders (e.g., schizophrenia) compared to the general population. Including antidepressant use in the case definition for the present study consequently resulted in cases that were primarily depression cases. Data for prescription use was only available after 1995, so parental psychiatric history was limited only to diagnosed psychiatric disorders, which most likely represent more severe cases.
Despite these limitations, the study has a number of strengths. This is the first study to apply psychiatric GRS in a population only of postpartum women. The study uses objective and well-validated65,66,67 register-based treated psychiatric episodes (i.e., diagnostic codes and redeemed prescriptions) rather than self-reported outcomes. Linkage with national registers also enables assessment of additional risk factors such as prior psychiatric history and family history. Finally, selection from a nationally representative sample increases our generalizability to broader populations, which is especially important when assessing other risk factors in addition to genetic liability.
We show evidence that genetic liability for major depression is associated with postpartum psychiatric disorders, suggesting genetic risk scores can provide additional information about risk not encompassed solely in simple measures of family history, however, the predictive ability of MD GRS to identify postpartum psychiatric disorders was small. Our findings demonstrate that although GRS is not yet appropriate as a clinical tool, genetic information about the risk of lifetime psychiatric illness can reasonably be applied to the postpartum period in the research setting. As sample sizes of genetic studies in postpartum populations grow, applying GRS to investigate shared genetic mechanisms may provide insight into distinct attributes of postpartum disorders. If replicated, our results could act as first steps in guiding future work focused on investigations that integrate studies in genetic and environmental risk factors to ultimately define vulnerable groups at risk for psychiatric disorders following childbirth.
Munk-Olsen, T., Laursen, T. M., Pedersen, C. B., Mors, O. & Mortensen, P. B. New parents and mental disorders. JAMA 296, 2582–2589 (2006).
Meltzer-Brody S. et al. Obstetrical, pregnancy and socio-economic predictors for new-onset severe postpartum psychiatric disorders in primiparous women. Psychol. Med. 47, 1427–1441 (2017).
Kendell, R. E., Chalmers, J. C. & Platz, C. Epidemiology of puerperal psychoses. Br. J. Psychiatry.150, 662–673 (1987).
O’Hara, M. W. & Wisner, K. L. Perinatal mental illness: definition, description and aetiology. Best. Pract. Res.: Clin. Obstet. Gynaecol. 28, 3–12 (2014).
Viguera, A. C. et al. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am. J. Psychiatry 168, 1179–1186 (2011).
Howard, L. M. et al. Non-psychotic mental disorders in the perinatal period. Lancet 384, 1775–1788 (2014).
Di Florio, A. et al. Perinatal episodes across the mood disorder spectrum. JAMA Psychiatry 70, 168–175 (2013).
Munk-Olsen, T. et al. Risks and predictors of readmission for a mental disorder during the postpartum period. Arch. Gen. Psychiatry 66, 189–195 (2009).
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed (American Psychiatric Publishing, Arlington, VA, 2013).
World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th ed. (Geneva, 1992).
Ko, J. Y., Rockhill, K. M., Tong, V. T., Morrow, B. & Farr, S. L. Trends in postpartum depressive symptoms—27 States, 2004, 2008, and 2012. MMWR Morbidity Mortal. Wkly. Rep. 66, 153–158 (2017).
Postpartum Depression: Action Towards Causes and Treatment (PACT) Consortium. Heterogeneity of postpartum depression: a latent class analysis. Lancet Psychiatry 2, 59–67 (2015).
Putnam, K. T. et al. Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an International Consortium. Lancet Psychiatry 0366, 1–8 (2017).
Gavin, N. I. et al. Perinatal depression: a systematic review of prevalence and incidence. Obstet. Gynecol. 106, 1071–1083 (2005).
Vesga-López, O. et al. Psychiatric disorders in pregnant and postpartum women in the United States. Arch. Gen. Psychiatry 65, 805–815 (2008).
Sit, D., Rothschild, A. J. & Wisner, K. L. A review of postpartum psychosis. J. Women’s. Health 15, 352–368 (2006).
VanderKruik, R. et al. The global prevalence of postpartum psychosis: a systematic review. BMC Psychiatry 17, 272 (2017).
Munk-Olsen, T. et al. Perinatal psychiatric episodes: a population-based study on treatment incidence and prevalence. Transl. Psychiatry 6, e919 (2016).
Rasmussen, M.-L. H., Strøm, M., Wohlfahrt, J., Videbech, P. & Melbye, M. Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study. PLoS One 14, e1002392 (2017).
Jones, I. & Craddock, N. Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am. J. Psychiatry 158, 253–264 (2001).
Murphy-Eberenz, K. et al. Is perinatal depression familial? J. Affect. Disord. 90, 49–55 (2006).
Payne, J. L. et al. Familial aggregation of postpartum mood symptoms in bipolar disorder pedigrees. Bipolar Disord. 10, 38–44 (2008).
Munk-Olsen, T., Laursen, T. M., Meltzer-Brody, S., Mortensen, P. B. & Jones, I. Psychiatric disorders with postpartum onset. Arch. Gen. psychiatry 69, 428–434 (2012).
Chaudron, L. H. & Pies, R. W. The Relationship between Postpartum Psychosis and Bipolar Disorder: A Review. J. Clin. Psychiatry 64, 1284–1292 (2003).
Treloar, S. A., Martin, N. G., Bucholz, K. K., Madden, P. A. & Heath, A. C. Genetic influences on post-natal depressive symptoms: findings from an Australian twin sample. Psychological Med. 29, 645–654 (1999).
Forty, L. et al. Familiality of postpartum depression in unipolar disorder: results of a family study. Am. J. Psychiatry 163, 1549–1553 (2006).
Viktorin, A. et al. Heritability of perinatal depression and genetic overlap with nonperinatal depression. Am. J. Psychiatry 173, 158–165 (2016).
Wray, N., Goddard, M. & Visscher, P. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res. 17, 1520–1528 (2007).
Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668–681 (2018).
Stahl, E. et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat. Genet. 51, 793–803 (2019).
The International Schizoprenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 012, 1–5 (2009).
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).
Smoller, J. W. et al. Psychiatric genetics and the structure of psychopathology. Mol. Psychiatry 24, 409–420 (2019).
Grove, J. et al. Identification of common risk variants for autism spectrum disorder. Nat. Genet. 51, 431–444 (2019).
Byrne, E. M. et al. Applying polygenic risk scores to postpartum depression. Arch. Women’s. Ment. Health 17, 519–528 (2014).
Pedersen, C. B. et al. The iPSYCH2012 case-cohort sample: new directions for unravelling genetic and environmental architectures of severe mental disorders. Mol. Psychiatry 23, 6–14 (2018).
Mors, O., Perto, G. P. & Mortensen, P. B. The Danish psychiatric central research register. Scand. J. Public Health 39, 54–57 (2011).
World Health Organization. Thinking healthy: A manual for psychosocial management of perinatal depression. World Health Organization 2015; 1: 180.
Bauer, A. E. et al. Familiality of psychiatric disorders and risk of postpartum psychiatric episodes: a population-based cohort study. Am. J. Psychiatry 175, 783–791 (2018).
Wallach Kildemoes, H., Toft Sørensen, H. & Hallas, J. The Danish national prescription registry. Scand. J. Public Health 39, 38–41 (2011).
Nørgaard-Pedersen, B. & Hougaard, D. M. Storage policies and use of the Danish Newborn Screening Biobank. J. Inherit. Metab. Dis. 30, 530–536 (2007).
Hollegaard, M. V. et al. Genome-wide scans using archived neonatal dried blood spot samples. BMC Genomics 10, 297 (2009).
Lam, M. et al. RICOPILI: Rapid Imputation for COnsortias PIpeLIne. Bioinformatics. https://doi.org/10.1093/bioinformatics/btz633 (2019).
Schizophrenia Working Group of the Psychiatric Genomics Consortium, Ripke, S. et al. Biological Insights From 108 Schizophrenia-associated genetic loci. Nature 511, 421–427 (2014).
Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371–1379 (2013).
Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depressive disorder. Nat. Genet. 50, 668–681 (2018).
Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).
Agerbo, E. et al. Polygenic risk score, parental socioeconomic status, family history of psychiatric disorders, and the risk for Schizophrenia: A Danish Population-based study and meta-analysis. JAMA Psychiatry 72, 635–641 (2015).
International Consortium on Lithium Genetics. Association of polygenic score for Schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder a genome-wide association study. JAMA Psychiatry 75, 65–74 (2018).
Mavaddat, N. et al. Prediction of breast cancer risk based on profiling with common genetic variants. JNCI: J. Natl. Cancer Inst. 107, 1–15 (2015).
Jones, I. & Craddock, N. Do puerperal psychotic episodes identify a more familial subtype of bipolar disorder? Results of a family history study. Psychiatr. Genet. 12, 177–180 (2002).
Jones, I., Chandra, P. S., Dazzan, P. & Howard, L. M. Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. Lancet 384, 1789–1799 (2014).
Wesseloo, R. et al. Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. Am. J. Psychiatry 173, 117–127 (2016).
Reich, T. & Winokur, G. Postpartum psychoses in patients with manic depressive disease. J. Nerv. Ment. Dis. 151, 60–68 (1970).
Dean, C., Williams, R. J. & Brockington, I. F. Is puerperal psychosis the same as bipolar manic-depressive disorder? A family study. Psychological Med. 19, 637–647 (1989).
Cox, J., Holden, J. & Sagovsky, R. Detection of Postnatal Depression: Development of the 10-item Edinburgh Postnatal Depression Scale. Br. J. Psychiatry 150, 782–786 (1987).
Musliner, K. L. et al. Incidence of medically treated depression in Denmark among individuals 15‐44 years old: A comprehensive overview based on population registers. Acta Psychiatr. Scandinavica 139, 548–557 (2019).
McIntosh, A. M., Sullivan, P. F. & Lewis, C. M. Uncovering the Genetic Architecture of Major Depression. Neuron 102, 91–103 (2019).
Brainstorm Consortium et al. Analysis of shared heritability in common disorders of the brain. Science 360, pii: eaap8757.
Cross-Disorder Group of the Psychiatric Genomics Consortium. et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984–994 (2013).
Bloch, M. et al. Cortisol response to ovine corticotropin-releasing hormone in a model of pregnancy and parturition in euthymic women with and without a history of postpartum depression. J. Clin. Endocrinol. Metab. 90, 695–699 (2005).
Bloch, M., Daly, R. C. & Rubinow, D. R. Endocrine factors in the etiology of postpartum depression. Compr. Psychiatry 44, 234–246 (2003).
Schiller, C. E., Meltzer-Brody, S. & Rubinow, D. R. The role of reproductive hormones in postpartum depression. CNS Spectr. 20, 48–59 (2015).
Greenland, S. Tests for interaction in epidemiologic studies: a review and a study of power. Stat. Med. 2, 243–251 (1983).
Bock, C., Bukh, J., Vinberg, M., Gether, U. & Kessing, L. Validity of the diagnosis of a single depressive episode in a case register. Clin. Pract. Epidemiol. Ment. Health 5, 1–8 (2009).
Kessing, L. Validity of diagnoses and other clinical register data in patients with affective disorder. Eur. Psychiatry 13, 392–398 (1998).
Uggerby, P., Østergaard, S., Røge, R., Correll, C. & Nielsen, J. The validity of the schizophrenia diagnosis in the Danish psychiatric central research register is good. Dan. Med. J. 60, A4578 (2013).
This study was funded by the National Institutes of Mental Health (1R01MH104468) to S.M.-B., principal investigator, and co-investigators (T.M.-O. and P.S.) and also supports A.E.B., T.M.-O. and the other iPSYCH researchers are supported by The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) LuF Grant R155-2014-1724. X.L. is supported by the Danish Council for Independent Research (DFF-5053-00156B). N.R.W. and E.M.B. acknowledge funding from the Australian National Health and Medical Research Council (1078901, 1087889, 1113400, 1145645). S.M.-B. receives research grant support from Sage Therapeutics and Janssen. We gratefully acknowledge 23andMe for the summary statistics used to generate the polygenic risk scores.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bauer, A.E., Liu, X., Byrne, E.M. et al. Genetic risk scores for major psychiatric disorders and the risk of postpartum psychiatric disorders. Transl Psychiatry 9, 288 (2019). https://doi.org/10.1038/s41398-019-0629-9